GAIN THERAPEUTICS INC (GANX) Institutional Ownership Changes & 13F Activity

GAIN THERAPEUTICS INC (GANX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Susquehanna International Group, Llp, Gsa Capital Partners Llp, Jane Street Group, Llc, Marshall Wace, Llp, and Squarepoint Ops Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Citadel Advisors LlcBuy+129,624+520.6%154,524$313.68KQ2 2026Sep 02, 2026
Mercer Global Advisors IncBuy+10,00010,000$20.30KQ2 2026Aug 19, 2026
Susquehanna International Group, LlpSell-353,061-81.9%78,206$158.76KQ2 2026Aug 14, 2026
Jane Street Group, LlcSell-161,255-74.4%55,628$112.92KQ2 2026Aug 14, 2026
Squarepoint Ops LlcBuy+136,359136,359$276.81KQ2 2026Aug 14, 2026
Potomac Capital Management, Inc.Sell-62,200-6.2%946,400$1.92MQ2 2026Aug 14, 2026
Xtx Topco LtdBuy+55,29455,294$112.25KQ2 2026Aug 14, 2026
Jones Financial Companies LllpSell-23,023-3.6%608,592$1.07MQ2 2026Aug 14, 2026
Two Sigma Securities, LlcBuy+12,73912,739$25.86KQ2 2026Aug 14, 2026
Group One Trading LlcSell-2,596-40.5%3,808$7.73KQ2 2026Aug 14, 2026
Osaic Holdings, Inc.Buy+2,0002,000$4.06KQ2 2026Aug 14, 2026
Wells Fargo & Company/MnSell-1,650-14.9%9,400$19.08KQ2 2026Aug 14, 2026
Barclays PlcBuy+1,3521,352$2.75KQ2 2026Aug 14, 2026
Marshall Wace, LlpBuy+153,758+8.7%1,923,546$3.90MQ2 2026Aug 13, 2026
Vanguard Capital Management LlcBuy+80,383+20.1%480,269$974.95KQ2 2026Aug 13, 2026
Northern Trust CorpSell-16,984-14.9%97,013$196.94KQ2 2026Aug 13, 2026
Morgan StanleySell-13,680-9.8%125,972$255.72KQ2 2026Aug 13, 2026
Virtu Financial LlcBuy+10,330+96.7%21,015$43.00KQ2 2026Aug 13, 2026
Sanctuary Advisors, LlcBuy+10,00010,000$20.30KQ2 2026Aug 13, 2026
Ubs Group AgSell-5,477-2.5%215,012$436.48KQ2 2026Aug 13, 2026
Vanguard Fiduciary Trust CoBuy+1,555+0.7%231,534$470.01KQ2 2026Aug 13, 2026
Harbour Investments, Inc.Buy+10,74510,745$21.81KQ2 2026Aug 12, 2026
Geode Capital Management, LlcBuy+6,159+1.4%453,501$921.37KQ2 2026Aug 12, 2026
Jpmorgan Chase & CoBuy+1,7001,700$3.37KQ2 2026Aug 12, 2026
Stratos Wealth Partners, Ltd.Buy+68,379+52.0%200,000$406.00KQ2 2026Aug 11, 2026
Tower Research Capital Llc (Trc)Buy+2,815+51.1%8,321$16.89KQ2 2026Aug 11, 2026
Arax Advisory PartnersBuy+1,7001,700$3.45KQ2 2026Aug 10, 2026
Blackrock, Inc.Buy+49,911+22.2%274,957$558.16KQ2 2026Aug 07, 2026
Lpl Financial LlcBuy+13,000+12.5%117,251$238.02KQ2 2026Aug 07, 2026
Gsa Capital Partners LlpBuy+319,664+102.3%632,131$1.28MQ2 2026Aug 06, 2026
Showing 30 of 39

Frequently asked questions about GANX activity

  • Which institutional owners are buying GANX?

    Institutional owners buying GANX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in GANX activity?

    "Buy" means an investor increased their reported position in GANX compared to the prior reporting period. This reflects growing exposure to GAIN THERAPEUTICS INC (GANX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in GANX increasing?

    Institutional interest in GANX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.